≥ Very Good Partial Response |
Overall Cohort |
50.5% [108/214] (43.8%,57.2%) |
40.4% [84/208] (33.7%,47.1%) |
10.1% (0.6%,19.5%) |
1.50 (1.02,2.21) |
High Risk |
36.4% [4/11] (7.9%,64.8%) |
22.2% [2/9] (0.0%,49.4%) |
14.1% (−25.2%,53.5%) |
2.00 (0.27,14.70) |
Standard Risk |
50.0% [23/46] (35.6%,64.4%) |
43.1% [25/58] (30.4%,55.8%) |
6.9% (−12.4%,26.2%) |
1.32 (0.61,2.87) |
≥ Partial Response |
Overall Cohort |
81.3% [174/214] (76.1%,86.5%) |
70.2% [146/208] (64.0%,76.4%) |
11.1% (3.0%,19.2%) |
1.85 (1.17,2.91) |
High Risk |
72.7% [8/11] (46.4%,99.0%) |
77.8% [7/9] (50.6%,100.0%) |
−5.1% (−42.9%,32.8%) |
0.76 (0.10,5.96) |
Standard Risk |
82.6% [38/46] (71.7%,93.6%) |
72.4% [42/58] (60.9%,83.9%) |
10.2% (−5.7%,26.1%) |
1.81 (0.70,4.70) |